PMX-53 is an Orally Active Complement C5a Receptor Antagonist
C5a is an important inflammatory hypernociceptive mediator, acting by a mechanism independent of hypernociceptive cytokine release, but dependent on the presence of neutrophils. Especially, C5a is a complement activation product….
